ConductScience.org, home

Paper41486563

A Natural Sweetener-inducible Genetic Switch Controls Therapeutic Protein Expression in Mammals.

Qiao L and 16 others. Adv Sci (Weinh), 2026. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. A Natural Sweetener-inducible Genetic Switch Controls Therapeutic Protein Expression in Mammals. Papers, record 41486563. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41486563

Download JSON
Cell line
HeLa892 papers
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
A Natural Sweetener-inducible Genetic Switch Controls Therapeutic Protein Expression in Mammals.
PubMed
Journal
Adv Sci (Weinh)
PubMed
Year
2026
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2026-08-13
PubMed

Authors17

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Qiao LLonglianghttps://orcid.org/0000-0002-4480-1040
2Wang ZZhihao
3Tang SShasha
4Fang YYuan
5Yu GGuiling
6Qiu XXiaoting
7Niu LLingxue
8Yan TTao
9Liu XXingwan
10Ma XXiaoding
11Kong DDeqiang
12Zhou YYang
13Guan NNingzi
14Tian JJinzhong
15Wang MMeiyan
16Ye HHaifeng
17Cai FFengfeng

Source PubMed

Download CSV of authors

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Sweetening AgentsMajor topic
Animals
Mice
Humans
Diabetes Mellitus, Type 1
Disease Models, Animal
Obesity

Source PubMed

Download CSV of topics

Grants13

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
32171414National Natural Science Foundation of ChinaPubMed
32250010:32261160373:32430064National Natural Science Foundation of ChinaPubMed
BX20250121Postdoctoral Fellowship Program and China Postdoctoral Science FoundationPubMed
2025M772716Postdoctoral Fellowship Program and China Postdoctoral Science FoundationPubMed
23ZR1419500Natural Science Foundation of ShanghaiPubMed
CSTB2022NSCQ-MSX0461Natural Science Foundation of ChongqingPubMed
32401213Young Scientists Fund of the National Natural Science Foundation of ChinaPubMed
3250120102Young Scientists Fund of the National Natural Science Foundation of ChinaPubMed
2023ZD0501300Noncommunicable Chronic Diseases-National Science and Technology Major ProjectPubMed
23HC1410100:25HC2830300Science and Technology Commission of Shanghai MunicipalityPubMed
ZDTS24-RXSixth Cycle Key Discipline Funding from Tongji Hospital, Tongji UniversityPubMed
GJPY2337Sixth Cycle Key Discipline Funding from Tongji Hospital, Tongji UniversityPubMed
GJPY2402Sixth Cycle Key Discipline Funding from Tongji Hospital, Tongji UniversityPubMed

Source PubMed

Download CSV of grants

References38

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
126297965Rare sugar D-allulose: Potential role and therapeutic monitoring in maintaining obesity and type 2 diabetes mellitus.Pharmacol Ther2015https://conductscience.org/library/papers/26297965PubMed
234782743Genetic-code-expanded cell-based therapy for treating diabetes in mice.Nat Chem Biol2022https://conductscience.org/library/papers/34782743PubMed
336658306Substantial Improvement of an Epimerase for the Synthesis of D-Allulose by Biosensor-Based High-Throughput Microdroplet Screening.Angew Chem Int Ed Engl2023https://conductscience.org/library/papers/36658306PubMed
434616030Engineering living therapeutics with synthetic biology.Nat Rev Drug Discov2021https://conductscience.org/library/papers/34616030PubMed
527168355Sugar replacers: from technological challenges to consequences on health.Curr Opin Clin Nutr Metab Care2016https://conductscience.org/library/papers/27168355PubMed
630933864From synthetic biology to human therapy: engineered mammalian cells.Curr Opin Biotechnol2019https://conductscience.org/library/papers/30933864PubMed
725030908Antagonistic control of a dual-input mammalian gene switch by food additives.Nucleic Acids Res2014https://conductscience.org/library/papers/25030908PubMed
831645456A green tea-triggered genetic control system for treating diabetes in mice and monkeys.Sci Transl Med2019https://conductscience.org/library/papers/31645456PubMed
935140213An optogenetic approach for regulating human parathyroid hormone secretion.Nat Commun2022https://conductscience.org/library/papers/35140213PubMed
1031285633A fully human transgene switch to regulate therapeutic protein production by cooling sensation.Nat Med2019https://conductscience.org/library/papers/31285633PubMed
1110859354Exploring the sequence space for tetracycline-dependent transcriptional activators: novel mutations yield expanded range and sensitivity.Proc Natl Acad Sci U S A2000https://conductscience.org/library/papers/10859354PubMed
1217827215Vitamin H-regulated transgene expression in mammalian cells.Nucleic Acids Res2007https://conductscience.org/library/papers/17827215PubMed
1337384125Engineering natural molecule-triggered genetic control systems for tunable gene- and cell-based therapies.Synth Syst Biotechnol2023https://conductscience.org/library/papers/37384125PubMed
1432995548Biosensor-based enzyme engineering approach applied to psicose biosynthesis.Synth Biol (Oxf)2019https://conductscience.org/library/papers/32995548PubMed
1519549857Controlling transgene expression in subcutaneous implants using a skin lotion containing the apple metabolite phloretin.Proc Natl Acad Sci U S A2009https://conductscience.org/library/papers/19549857PubMed
1636906608Synthetic biology-inspired cell engineering in diagnosis, treatment, and drug development.Signal Transduct Target Ther2023https://conductscience.org/library/papers/36906608PubMed
1729858606Designing cell function: assembly of synthetic gene circuits for cell biology applications.Nat Rev Mol Cell Biol2018https://conductscience.org/library/papers/29858606PubMed
1839604418A sensitive red/far-red photoswitch for controllable gene therapy in mouse models of metabolic diseases.Nat Commun2024https://conductscience.org/library/papers/39604418PubMed
1934216875Emerging mammalian gene switches for controlling implantable cell therapies.Curr Opin Chem Biol2021https://conductscience.org/library/papers/34216875PubMed
2030833703Low-calorie diets in the management of type 2 diabetes mellitus.Nat Rev Endocrinol2019https://conductscience.org/library/papers/30833703PubMed

See all 38 referencesDownload CSV of references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41486563

GET https://conductscience.org/api/papers/v1/41486563/references?page=2